Bexarotene: A Rare Cause of Misleading Thyroid Function Tests

Abstract

Bexarotene is a very rare cause of central hypothyroidism (CH) and its effects have been reported to be dosedependent; however, the available data in the literature on dose-dependent effects are variable. The standard practice of monitoring thyroid function using thyroid-stimulating hormone (TSH) to adjust levothyroxine (LT4) dose does not apply to bexarotene since it causes CH. In CH, TSH is not reliable. Hence free tetraiodothyronine (fT 4) level is used to monitor and adjust the LT4 dose. We report a case of an 81year-old Caucasian male with cutaneous T-cell lymphoma (CTCL) who was treated with bexarotene. His pretreatment TSH was normal at 1.6 µIU/mL (reference range: 0.46-4.68 µIU/mL). Post-bexarotene, the total tetraiodothyronine (T 4) level was within the reference range, but a downward trend was noted. Eventually, total triiodothyronine (T 3) dropped to a low level of 0.61 ng/mL (reference range: 0.97-1.69 ng/mL), and LT4 was initiated. Bexarotene dose was increased, but LT4 was not increased by the primary physician who relied on TSH level, which was low, and hence the existing LT4 dose was maintained. The patient had persistent symptoms of hypothyroidism and, eventually, a diagnosis of CH was made. The symptoms of hypothyroidism improved after normalizing fT 4 , with an increase in the LT4 dose. This case represents an example of missed CH due to bexarotene, which led to suboptimal LT4 replacement impacting the quality of life for the patient.

Association of hypothyroidism with outcomes in hospitalized adults with COVID‐19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID‐19 Registry

“…However, interpretation of thyroid function tests with outcomes could be complex as both critical illness 50 and many medications are known to affect thyroid function tests. 51 , 52 , 53 Fourth, we did not include various prognostic markers in the final analysis such as C‐reactive protein, estimated glomerular filtration rate and so forth for adjustment due to lack of data.…”

“…Third, we did not have baseline data for thyroid lab panel and preadmission use of thyroid medication, especially levothyroxine for correlation with outcomes; therefore, we could not differentiate between patients with restored euthyroid state, patients still having a hormonal deficit and patients with over‐replacement. However, interpretation of thyroid function tests with outcomes could be complex as both critical illness 50 and many medications are known to affect thyroid function tests 51–53 . Fourth, we did not include various prognostic markers in the final analysis such as C‐reactive protein, estimated glomerular filtration rate and so forth for adjustment due to lack of data.…”

Atypical Thyroid Function Tests and Thyroid Hormone Resistance

“…However, our patient did not have any family history suggestive of thyroid hormone resistance. Many medications can also affect thyroid labs [2][3][4]. He was not taking any medications, biotin, or had any iodinated contrast that could have affected thyroid labs.…”